pentoxifylline has been researched along with Anorexia in 8 studies
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on evidence that suggests pentoxifylline can inhibit tumor necrosis factor, we set out to evaluate the activity and toxicity of this drug in patients with cancer-associated anorexia and/or cachexia." | 9.08 | Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. ( Chong, SF; Ghosh, C; Goldberg, RM; Hestorff, RD; Krook, JE; Loprinzi, CL; Mailliard, JA; O'Fallon, JR; Reuter, NF; Shanahan, TG, 1995) |
| "Cardiac cachexia was rapidly induced with monocrotaline in Sprague-Dawley rats." | 5.35 | Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. ( Booth, FW; Lees, SJ; Steffen, BT, 2008) |
| "Based on evidence that suggests pentoxifylline can inhibit tumor necrosis factor, we set out to evaluate the activity and toxicity of this drug in patients with cancer-associated anorexia and/or cachexia." | 5.08 | Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. ( Chong, SF; Ghosh, C; Goldberg, RM; Hestorff, RD; Krook, JE; Loprinzi, CL; Mailliard, JA; O'Fallon, JR; Reuter, NF; Shanahan, TG, 1995) |
| "Cancer anorexia and cachexia are two distinct syndromes which may have synergistic effects in a patient." | 2.41 | [Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions]. ( Gastell, S; Lochs, H; Ockenga, J; Pirlich, M, 2002) |
| "Cardiac cachexia was rapidly induced with monocrotaline in Sprague-Dawley rats." | 1.35 | Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. ( Booth, FW; Lees, SJ; Steffen, BT, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalantar-Zadeh, K | 1 |
| Anker, SD | 1 |
| Horwich, TB | 1 |
| Fonarow, GC | 1 |
| Steffen, BT | 1 |
| Lees, SJ | 1 |
| Booth, FW | 1 |
| Ockenga, J | 1 |
| Pirlich, M | 1 |
| Gastell, S | 1 |
| Lochs, H | 1 |
| Argilés, JM | 1 |
| Busquets, S | 1 |
| López-Soriano, FJ | 1 |
| Goldberg, RM | 1 |
| Loprinzi, CL | 1 |
| Mailliard, JA | 1 |
| O'Fallon, JR | 1 |
| Krook, JE | 1 |
| Ghosh, C | 1 |
| Hestorff, RD | 1 |
| Chong, SF | 1 |
| Reuter, NF | 1 |
| Shanahan, TG | 1 |
| Haslett, PA | 1 |
| Raza, A | 1 |
| Qawi, H | 1 |
| Lisak, L | 1 |
| Andric, T | 1 |
| Dar, S | 1 |
| Andrews, C | 1 |
| Venugopal, P | 1 |
| Gezer, S | 1 |
| Gregory, S | 1 |
| Loew, J | 1 |
| Robin, E | 1 |
| Rifkin, S | 1 |
| Hsu, WT | 1 |
| Huang, RW | 1 |
| Porter, MH | 1 |
| Hrupka, BJ | 1 |
| Altreuther, G | 1 |
| Arnold, M | 1 |
| Langhans, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Patients With Anorexia Associated With Advanced Lung Cancer: Randomized Double Blind Clinical Trial[NCT02802540] | Phase 2/Phase 3 | 78 participants (Anticipated) | Interventional | 2014-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for pentoxifylline and Anorexia
| Article | Year |
|---|---|
Nutritional and anti-inflammatory interventions in chronic heart failure.
Topics: Amino Acids; Anorexia; Antioxidants; Appetite Stimulants; Cachexia; Comorbidity; Dietary Supplements | 2008 |
[Tumour anorexia--tumour cachexia in case of gastrointestinal tumours: standards and visions].
Topics: Adrenal Cortex Hormones; Algorithms; Anorexia; Body Weight; Cachexia; Cyclooxygenase Inhibitors; Die | 2002 |
The pivotal role of cytokines in muscle wasting during cancer.
Topics: Animals; Anorexia; Antibodies; Cachexia; Cytokines; Humans; Models, Biological; Muscle, Skeletal; Mu | 2005 |
Anticytokine approaches to the treatment of anorexia and cachexia.
Topics: Anorexia; Cachexia; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-6; Pentoxifylline; | 1998 |
1 trial available for pentoxifylline and Anorexia
| Article | Year |
|---|---|
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial.
Topics: Aged; Anorexia; Appetite; Body Weight; Cachexia; Double-Blind Method; Female; Humans; Male; Middle A | 1995 |
3 other studies available for pentoxifylline and Anorexia
| Article | Year |
|---|---|
Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
Topics: Animals; Anorexia; Blotting, Western; Body Weight; Cachexia; Eating; Enzyme-Linked Immunosorbent Ass | 2008 |
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols | 2000 |
Inhibition of TNF-alpha production contributes to the attenuation of LPS-induced hypophagia by pentoxifylline.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Anorexia; Drug Tolerance; Humans; Hyperphagia; Interleuk | 2000 |